enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
Stocks in this Quantisnow insightHealth Care · Finance
Historical context for ENGN
Across the 6 sessions after earlier ENGN headlines, the stock closed higher 4 times and lower 2 times, with a median move of 3.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ENGN | SPY |
|---|---|---|---|
| Dec 23, 2025 | enGene Reports Full Year 2025 Financial Results and Provides Business Update | +5.1% | +0.5% |
| Dec 2, 2025 | enGene's Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness | -0.6% | +0.2% |
| Nov 25, 2025 | enGene to Present at the Piper Sandler 37th Annual Healthcare Conference | +4.0% | +0.9% |
| Nov 13, 2025 | enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrantsand 1 other headline that session | -2.9% | -1.7% |
| Nov 11, 2025 | enGene Holdings upgraded by Raymond James with a new price targetand 2 other headlines that session | +46.8% | +0.2% |
| Nov 7, 2025 | enGene to Participate in Upcoming Investor Conferences | +0.7% | +0.1% |
Keep researching ENGN
- What is Earnings call?A conference call or webcast where company management discusses quarterly results and guidance and takes questions from analysts.
- Earnings season calendarEarnings season starts about two weeks after each quarter ends and runs roughly six weeks. Learn the timing, BMO and AMC releases, whisper numbers and guidance.
- ENGN insider tradesEvery buy and sale reported by enGene Therapeutics Inc. officers, directors and large holders.
- ENGN earnings historyPast enGene Therapeutics Inc. earnings releases, newest first.
- ENGN financial statementsRevenue, profit, cash flow and balance sheet from enGene Therapeutics Inc.'s SEC filings.
Quantisnow market dataNASDAQ
ENGN
enGene Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for ENGN
Full ENGN profile on Quantisnow Follow ENGN and get a push notification the moment its next story breaks.